| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 03, 2014 | VP - Global Franchise | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 633 | $14.69 | 25,818 | |
| Aug 03, 2014 | SVP, Business Development | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 530 | $14.69 | 31,280 | |
| Aug 03, 2014 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 357 | $14.69 | 31,249 | |
| Aug 03, 2014 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 759 | $14.69 | 30,490 | |
| Aug 03, 2014 | SVP, GM - Oncology | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 893 | $14.69 | 29,597 | |
| Jul 25, 2014 | CTO and COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,344 | -- | 24,187 | |
| Jul 25, 2014 | CTO and COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,377 | -- | 15,377 | |
| Jul 25, 2014 | CTO and COO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,125 | -- | 7,125 | |
| Jul 25, 2014 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,884 | -- | 185,174 | |
| Jul 25, 2014 | Director, President and CEO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 88,861 | -- | 88,861 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.